bullish
Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?
442 Views16 Dec 2020 09:23
This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and also provided some thoughts on valuation.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Pre-IPO Raily Aesthetic Medicine (2135.HK) - Here Are the Concerns24 Dec 2020
- Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns23 Dec 2020
- Pre-IPO Yidu Tech Inc - The Future Performance Is Worth Looking Forward To22 Dec 2020
- China Healthcare Weekly (Dec.11)14 Dec 2020
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
- Pre-IPO Jacobio Pharmaceuticals - Insights on Pipeline08 Dec 2020
x